Table 2.
Variable | Excellent Outcome
|
Independent Outcome
|
||||
---|---|---|---|---|---|---|
mRS 0–1 (N=32) |
mRS 2–6 (N=21) |
P Value | mRS 0–2 (N=37) |
mRS 3–6 (N = 16) |
P Value | |
Age, mean±SEM | 65.1±2.8 | 75.1±2.3 | 0.008 | 65.5±2.5 | 77.3±2.4 | 0.007 |
NIHSS | 0.002 | <0.001 | ||||
0–4 | 15 | 4 | 17 | 2 | ||
5–11 | 13 | 5 | 16 | 2 | ||
>11 | 4 | 12 | 4 | 12 | ||
Pre-tPA glucose, mg/dL; mean±SEM | 119.2±4.8 | 134.6±15.9 | 0.841 | 119.1±4.3 | 139.7±20.7 | 0.985 |
Onset to treatment, minutes; mean±SEM | 139.6±5.6 | 140.4±6.5 | 0.93 | 140.5±5.1 | 138.6±7.6 | 0.84 |
DWI volume, cm3; mean±SEM | 11.4±3.4 | 30.6±9.8 | 0.033 | 11.9±3.4 | 32.3±12.1 | 0.037 |
FLAIR volume, cm3; mean±SEM | 6.1±2.1 | 68.2±21.0 | <0.001 | 8.6±2.6 | 81.7±26.6 | <0.001 |
Volume change, cm3; mean±SEM | −5.3±3.4 | 37.6±17.5 | 0.001 | −3.3±3.2 | 46.4±22.6 | 0.003 |
Is mismatch present?* | 1.0 | 1.0 | ||||
Yes | 25 | 12 | 29 | 8 | ||
No | 6 | 2 | 6 | 2 | ||
Is mismatch present?† | 0.179 | 0.178 | ||||
Yes | 24 | 21 | 27 | 18 | ||
No | 5 | 10 | 6 | 9 | ||
Volume decrease ≥30% | 0.004 | 0.013 | ||||
Yes | 17 | 3 | 18 | 2 | ||
No | 15 | 18 | 19 | 14 | ||
Volume increase ≥30% | 0.102 | 0.127 | ||||
Yes | 14 | 14 | 17 | 11 | ||
No | 18 | 7 | 20 | 5 | ||
Volume decrease ≥5 cm3 | 0.160 | 0.299 | ||||
Yes | 10 | 3 | 11 | 2 | ||
No | 22 | 18 | 26 | 14 | ||
Volume increase ≥5 cm3 | 0.002 | 0.002 | ||||
Yes | 5 | 12 | 7 | 10 | ||
No | 27 | 9 | 30 | 6 |
N=45; mismatch is defined as volume of mean transit time delay 20% larger than volume of DWI abnormality.
Includes data from 15 patients who died before follow-up MRI was done but who had baseline mean transit time images.